Literature DB >> 9259259

A case of cytophagic histiocytic panniculitis: successful treatment of recurrent attacks with steroid pulse therapy and oral cyclosporin A.

S Nakane1, Y Kawabe, K Eguchi, A Kita, A Mizokami, H Yamasaki, S Nagataki.   

Abstract

We report a 35-year-old man, who had been diagnosed with Weber-Christian disease, presented with acute onset of high fever, malaise, jaundice and hepatosplenomegaly with subcutaneous nodules. Laboratory tests showed elevated serum ferritin and liver enzymes, especially lactate dehydrogenase (LDH), with pancytopenia and coagulation abnormalities. Peripheral blood and bone marrow examinations showed erythro-, leuko- and thrombo-phagocytic histiocytes and macrophages. The patient developed the same clinical features seven years ago. Based on diagnosis of cytophagic histiocytic panniculitis, the patient was treated with steroid pulse therapy and oral cyclosporin A. The combination therapy caused a marked improvement in the clinical condition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259259     DOI: 10.1007/bf02242462

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  Histiocytic cytophagic panniculitis: molecular evidence for a clonal T-cell disorder.

Authors:  P Hytiroglou; R G Phelps; D J Wattenberg; J A Strauchen
Journal:  J Am Acad Dermatol       Date:  1992-08       Impact factor: 11.527

2.  Cytophagic histiocytic panniculitis evolving into total lipodystrophy.

Authors:  T Yanagawa; A Yokoyama; K Noya; Y Kasuga; I Takei; H Maruyama; K Kataoka; T Saruta; S Kawamura; K Toyama
Journal:  South Med J       Date:  1990-11       Impact factor: 0.954

3.  Cytophagic panniculitis and B cell lymphoma.

Authors:  M S Peters; R K Winkelmann
Journal:  J Am Acad Dermatol       Date:  1985-11       Impact factor: 11.527

4.  Accumulation and release of isoferritins during incubation in vitro of human peripheral blood mononuclear cells.

Authors:  M Worwood; D Hourahane; B M Jones
Journal:  Br J Haematol       Date:  1984-01       Impact factor: 6.998

5.  Cytophagic histiocytic panniculitis. A variant of malignant histiocytosis.

Authors:  D R Barron; B R Davis; J R Pomeranz; J D Hines; C H Park
Journal:  Cancer       Date:  1985-06-01       Impact factor: 6.860

6.  Virus associated hemophagocytic syndrome.

Authors:  R W McKenna; R J Risdall; R D Brunning
Journal:  Hum Pathol       Date:  1981-05       Impact factor: 3.466

7.  Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity.

Authors:  S Ohga; A Matsuzaki; M Nishizaki; T Nagashima; T Kai; M Suda; K Ueda
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-08

8.  Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor.

Authors:  E Ishii; S Ohga; T Aoki; S Yamada; M Sako; H Tasaka; A Kuwano; M Sasaki; Y Tsunematsu; K Ueda
Journal:  Acta Haematol       Date:  1991       Impact factor: 2.195

9.  Cytophagic histiocytic panniculitis with atypical lymphocytes in peripheral blood.

Authors:  S Makino; J Kamura
Journal:  Intern Med       Date:  1992-11       Impact factor: 1.271

Review 10.  Successful treatment of severe cytophagic histiocytic panniculitis with cyclosporine A.

Authors:  B E Ostrov; B H Athreya; A H Eichenfield; D P Goldsmith
Journal:  Semin Arthritis Rheum       Date:  1996-06       Impact factor: 5.532

View more
  1 in total

1.  Cytophagic histiocytic panniculitis, hemophagocytic lymphohistiocytosis and undetermined autoimmune disorder: reconciling the puzzle.

Authors:  Claudia Pasqualini; Mauro Jorini; Ines Carloni; Mirella Giangiacomi; Valentina Cetica; Maurizio Aricò; Fernando Maria de Benedictis
Journal:  Ital J Pediatr       Date:  2014-02-13       Impact factor: 2.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.